Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs TD SYNNEX Corporation Common Stock (SNX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs TD SYNNEX Corporation Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43 (market cap $7.04B), while TD SYNNEX Corporation Common Stock trades at $258.28 (market cap $22.02B). The key difference: TD SYNNEX Corporation Common Stock is far larger — about 3.1× Ionis Pharmaceuticals Inc. Common Stock's market cap, and TD SYNNEX Corporation Common Stock pays a 0.7% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and TD SYNNEX Corporation Common Stock for 0 Days on average.
| IONS | SNX | |
|---|---|---|
Market Cap | $7.04B | $22.02B |
Volume | 2,977,440 | 614,208 |
Sector | Health | Technology |
52-Week High | $86.50 | $290.14 |
52-Week Low | $42.38 | $142.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $26.79B |
Dividend Yield | — | 0.7% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About TD SYNNEX Corporation Common Stock
TD SYNNEX Corporation is a global IT distributor and solutions aggregator that distributes endpoint devices and data-center technologies from technology vendors to resellers and customers worldwide.
Read more on SNX →
